a Better Bubble™

EQ

Mission Control Acquired by LeagueSpot

1 year ago

The co-founders celebrating an exit are SLU student alums who joined the St. Louis startup ecosystem following graduation. In our view, this acquisition news reflects well on the city's ongoing efforts to develop a student-to-startup pipeline that retains talent in the region.

The post Mission Control Acquired by LeagueSpot appeared first on EQ.

Jonathan Allen

Shared Services in the St. Louis AgTech and BioTech Innovation Districts

1 year 4 months ago

EQ's resident expert in economic complexity theory, Mike Fabrizi, explains the different shared services offered by St. Louis' innovation districts. From lab equipment to utilities management, shared services cuts down on outsourcing costs and increases the chance of your AgTech or BioTech startup succeeding in these resource intensive sectors.

The post Shared Services in the St. Louis AgTech and BioTech Innovation Districts appeared first on EQ.

Mike Fabrizi

Remembering Our Beloved Community Builder, Patty Hagen

1 year 4 months ago

My own experience as a coworking member (three years, 2016-2019) and the reflections of other T-REX associates have much in common.

Patty Hagen, T-REX’s Executive Director, is integral to our collective memory and she stands out as our community builder. We owe her memory both affection and gratitude. Here, we stop for a moment to pay our respects.

The post Remembering Our Beloved Community Builder, Patty Hagen appeared first on EQ.

Jonathan Allen

T-REX “Makes Hard Decision” to Solve Overly Complicated Legacy of Organization Names

1 year 6 months ago

For those aware of T-REX's history of operating under many names, the potential for confusion around their name seems patently obvious. So, it comes as no surprise that the organization chose today, the First April of the Month, to rebrand the organization.

The post T-REX “Makes Hard Decision” to Solve Overly Complicated Legacy of Organization Names appeared first on EQ.

Jonathan Allen

Big Pharma Teams Up with St. Louis Immunotherapy Startup & Why it Matters

1 year 9 months ago

Immunophotonics has announced a research collaboration with the innovation subsidiary of a major pharmaceutical company to study the effect of combining an immunotherapy drug with routine treatments for cancer in order to reduce the risk of recurrence. EQ speaks to the STL startup founder and explains 4 reasons why this is good news for St. Louis.

The post Big Pharma Teams Up with St. Louis Immunotherapy Startup & Why it Matters appeared first on EQ.

Jonathan Allen

Big Pharma Teams Up with St. Louis Vaccine Startup & Why it Matters

1 year 9 months ago

Omniose, a St. Louis biotech startup focused on developing vaccines for bacterial infections, has entered into a 3-year research agreement with AstraZeneca, the gigantic pharmaceutical firm known for developing Britain’s COVID-19 vaccine. EQ speaks to the STL startup founder and explains 2 reasons why this is good news for St. Louis.

The post Big Pharma Teams Up with St. Louis Vaccine Startup & Why it Matters appeared first on EQ.

Jonathan Allen